Neurology Minute

Dr. Mayra Montalvo discusses her abstract, " Acute Symptomatic Seizures Secondary to Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder" [MOGAD]. Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-003525.html

Dr. Ann McKee continues her discussion on her recent study, which found that NFL players are at a higher risk for amyotrophic lateral sclerosis (ALS). Show references: https://journals.lww.com/neurotodayonline/fulltext/2022/02030/professional_football_players_are_at_a_higher_risk.5.aspx

Dr. Ming Lim discusses the diagnosis and management of opsoclonus myoclonus ataxia syndrome (OMAS) in children. Show references: https://nn.neurology.org/content/9/3/e1153  

Dr. Nassim Zecavati  discusses one of the 2022 Neurology on the Hill issues: Extend Telehealth Flexibilities . Follow the event on social media using #NOH22. Show references: https://www.aan.com/events/neurology-on-the-hill

Dr. Tyler Allison discusses one of the 2022 Neurology on the Hill issues: Address Overly Burdensome Barriers to Care. Follow the event on social media using #NOH22. Show references:  https://www.aan.com/events/neurology-on-the-hill  

Dr. Umer Najib discusses one of the 2022 Neurology on the Hill issues: Neurology Workforce. Follow the event on social media using #NOH22. Show references: https://www.aan.com/events/neurology-on-the-hill

Dr. Rae Bacharach discusses the  Neurology Today  article, "Multiple Sclerosis Costs More Than $85 Billion Annually, New Study Finds the Policy Changes That Could Fix That". Show references: https://journals.lww.com/neurotodayonline/Fulltext/2022/05050/Multiple_Sclerosis_Costs_More_Than__85_Billion.4.aspx

Dr. Ann McKee discusses her recent study, which found that NFL players are at a higher risk for amyotrophic lateral sclerosis (ALS). Show references: https://journals.lww.com/neurotodayonline/fulltext/2022/02030/professional_football_players_are_at_a_higher_risk.5.aspx

Dr. Anne Oaklander discusses the association of long COVID with incident polyneuropathy affecting the small-fiber axons. Show references: https://nn.neurology.org/content/9/3/e114 6

In part 2 of a 2 part series, Francesco Brigo, MD, discusses his article, "Approach to the Medical Treatment of Epilepsy" from the April Continuum Epilepsy issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/MedTreatEpilepsy.      

In part 1 of a 2 part series, Francesco Brigo, MD, discusses his article, "Approach to the Medical Treatment of Epilepsy" from the April Continuum Epilepsy issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/MedTreatEpilepsy.

Dr. Nancy Newman discusses her abstract, "The Phase III REFLECT Trial: Efficacy and Safety of Bilateral Gene Therapy for Leber Hereditary Optic Neuropathy". Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-000928.html

Dr. Andreas Rowald discusses the efficacy of activity-dependent spinal cord neuromodulation, which was shown to rapidly restore trunk and leg motor functions in patients with spinal cord injury after complete paralysis.

Dr. Shobi Sivathamboo discusses the incidence of serious cardiac arrhythmias detected by subcutaneous cardiac monitors in patients with chronic drug-resistant epilepsy. Show references: https://n.neurology.org/content/early/2022/04/06/WNL.0000000000200173"

Dr. Justin Abbatemarco discusses Alexander disease. 

Dr. Justin Abbatemarco discusses Adrenoleukodystrophy (ALD).  

Dr. Michael Kentris discusses psychogenic non-epileptic spells [PNES].

Dr. Antoine Gavoille discusses the prognostic factors and efficacy of immunosuppressive treatments for spinal cord sarcoidosis. Show references: https://n.neurology.org/content/98/14/e1479

Show references:

Dr. Shuvro Roy discusses TNF-alpha Antagonism.

Dr. Shuvro Roy discusses CTLA4 Haploinsufficiency.

Audrey Blazek, a 4th-year medical student at Rush Medical College, discusses her abstract, "Combined Prophylactic Treatment of Chronic Migraine with OnabotulinumtoxinA and Anti-CGRP Monoclonal Antibodies". Show references: https://index.mirasmart.com/aan2022/PDFfiles/AAN2022-000014.html

Dr. Mark Keezer discusses the risk of sudden death and cardiac arrhythmia in patients utilizing lamotrigine to treat epilepsy.  Show references: https://n.neurology.org/content/early/2022/03/08/WNL.0000000000200164

Dr. Michael Fox discusses whether connectivity between sites of deep brain stimulation (DBS) and other brain regions is associated with DBS-induced cognitive decline in patients with Parkinson's disease. Show references: https://academic.oup.com/brain/advance-article/doi/10.1093/brain/awac012/6509276?login=false

In part 2 of a 2 part series, Elaine Wirrell, MD, FRCP(C), FAAN, discusses her article, "Evaluation of First Seizure and Newly Diagnosed Epilepsy" from the April Continuum Epilepsy issue. This article and the accompanying Continuum Audio interview are open to all until July 1, 2022, at http://continpub.com/EvalFirstSeiz.